FDC (NSE:FDC) Other Gross PPE : ₹6,767 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is FDC Other Gross PPE?

FDC's Other Gross PPE for the quarter that ended in Mar. 2024 was ₹6,767 Mil.

FDC's quarterly Other Gross PPE declined from Sep. 2023 (₹6,888 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹6,767 Mil).

FDC's annual Other Gross PPE increased from Mar. 2022 (₹648 Mil) to Mar. 2023 (₹714 Mil) and increased from Mar. 2023 (₹714 Mil) to Mar. 2024 (₹6,767 Mil).

FDC Other Gross PPE Historical Data

The historical data trend for FDC's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC Other Gross PPE Chart

FDC Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Gross PPE

Get a 7-Day Free Trial

503.38

390.53

647.99

713.80

6,766.85

FDC Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															713.80	-	6,888.05	-	6,766.85

FDC Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

FDC (NSE:FDC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Other Gross PPE

Traded in Other Exchanges

531599:India

Address

C-3 Skyvistas, Near Versova Police Station, D.N. Nagar, Andheri (West), Mumbai, MH, IND, 400053

Website

https://www.fdcindia.com

FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.